| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $62.6M | +67.7% |
| R&D Expense | $68.1M | +28.1% |
| SG&A Expense | $50.4M | +88.2% |
| Operating Income | -$106.4M | -1539.1% |
| Pre-tax Income | -$131.2M | — |
| Income Tax | $0 | -100.0% |
| Net Income | -$134.1M | -9771.4% |
| EPS (Basic) | -$0.79 | +93.6% |
| EPS (Diluted) | -$0.79 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $75.6M | — |
| Accounts Receivable | $11.2M | -4.6% |
| Inventory | $1.8M | +55.0% |
| Current Assets | $172.7M | — |
| Total Assets | $241.6M | +58.4% |
| Current Liabilities | $27.8M | +304.2% |
| Long-term Debt | $25.1M | -49.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$97.3M | — |
| Capital Expenditures | $8.6M | -20.3% |
| Investing Cash Flow | -$57.9M | — |
| Financing Cash Flow | $148.2M | +193.2% |
| Free Cash Flow | -$105.8M | -855.3% |
| +93.6% |
| Total Liabilities |
| $127.2M |
| +1209.0% |
| Stockholders' Equity | $114.5M | +1473.6% |